423 related articles for article (PubMed ID: 24751222)
1. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
[TBL] [Abstract][Full Text] [Related]
2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
[TBL] [Abstract][Full Text] [Related]
4. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
Vinod SK; Caldwell K; Lau A; Fowler AR
J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
[TBL] [Abstract][Full Text] [Related]
5. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
6. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
7. Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy.
Georg P; Pötter R; Georg D; Lang S; Dimopoulos JC; Sturdza AE; Berger D; Kirisits C; Dörr W
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):653-7. PubMed ID: 21345618
[TBL] [Abstract][Full Text] [Related]
8. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
[TBL] [Abstract][Full Text] [Related]
9. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
[TBL] [Abstract][Full Text] [Related]
10. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract][Full Text] [Related]
11. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
Gao M; Albuquerque K; Chi A; Rusu I
Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
[TBL] [Abstract][Full Text] [Related]
12. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
13. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
14. Intermediate dose-volume parameters and the development of late rectal toxicity after MRI-guided brachytherapy for locally advanced cervix cancer.
Ujaimi R; Milosevic M; Fyles A; Beiki-Ardakani A; Carlone M; Jiang H; Lindsay P; Xie J; Gerber R; Croke J; Skliarenko J; Levin W; Han K
Brachytherapy; 2017; 16(5):968-975.e2. PubMed ID: 28757404
[TBL] [Abstract][Full Text] [Related]
15. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.
Levitchi M; Charra-Brunaud C; Quetin P; Haie-Meder C; Kerr C; Castelain B; Delannes M; Thomas L; Desandes E; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):314-21. PubMed ID: 22633813
[TBL] [Abstract][Full Text] [Related]
16. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
17. D2cm³/DICRU ratio as a surrogate of bladder hotspots localizations during image-guided adaptive brachytherapy for cervical cancer: assessment and implications in late urinary morbidity analysis.
Mazeron R; Dumas I; Rivin E; Martin V; Benhabib-Boukhelif W; Tailleur A; Guemnie-Tafo A; Martinetti F; Chargari C; Lefkopoulos D; Haie-Meder C
Brachytherapy; 2015; 14(2):300-7. PubMed ID: 25442061
[TBL] [Abstract][Full Text] [Related]
18. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
[TBL] [Abstract][Full Text] [Related]
20. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
